Literature DB >> 18373563

Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.

Eriko Ishibashi1, Yuichiro Eguchi, Takahisa Eguchi, Aki Matsunobu, Noriko Oza, Shunya Nakashita, Yoichiro Kitajima, Shigetaka Kuroki, Iwata Ozaki, Yasunori Kawaguchi, Yasushi Ide, Tsutomu Yasutake, Ryuichi Iwakiri, Toshihiko Mizuta, Naofumi Ono, Kazuma Fujimoto.   

Abstract

BACKGROUND AND AIM: Abdominal obesity, a component of metabolic syndrome, is a major risk factor for non-alcoholic fatty liver disease (NAFLD). In recent worldwide definitions of metabolic syndrome, waist measurement has been proposed as a simple and useful estimate of abdominal obesity, taking into account gender differences in waist circumference. The present cross-sectional study investigated the correlation of hepatic fat accumulation and waist circumference in Japanese NAFLD patients to determine if there are gender differences in this relationship.
METHODS: Consecutive patients (n = 2111) who had at least one of two criteria for liver disease (alanine aminotransferase [ALT] level >30 IU/mL and aspartate aminotransferase [AST]/ALT ratio <1) underwent abdominal ultrasonography. Patients positive for hepatitis B virus, hepatitis C virus or autoimmune antibodies and whose alcohol intake was >20 g/day were excluded. Patients with NAFLD underwent abdominal computed tomography. Hepatic fat accumulation was estimated by liver/spleen attenuation ratio (L/S ratio) and visceral adipose accumulation was measured as visceral fat area (VFA) at the umbilical level.
RESULTS: Of the 221 NAFLD patients, 103 were females. In males, the relationship between L/S ratio and waist circumference was negative (r =-0.356, P < 0.01), and there was no correlation in the female group. The relationship between L/S ratio and VFA was negative in both groups (males: r = -0.269, P < 0.01; females: r = -0.319, P < 0.01). Subcutaneous fat area/total fat area ratio at the umbilical level was larger in females than in males (P < 0.01).
CONCLUSIONS: In NAFLD patients, waist measurement is more susceptible to gender differences than VFA.

Entities:  

Mesh:

Year:  2008        PMID: 18373563     DOI: 10.1111/j.1440-1746.2008.05366.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Shingo Hibino; Akira Yamanoi
Journal:  J Gastroenterol       Date:  2011-11-09       Impact factor: 7.527

2.  The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Toshihiko Mizuta; Yoshio Sumida; Eriko Ishibashi; Yoichiro Kitajima; Hiroshi Isoda; Hiroko Horie; Takaya Tashiro; Eri Iwamoto; Hirokazu Takahashi; Takuya Kuwashiro; Shu Soejima; Yasunori Kawaguchi; Yasutomo Oda; Sei Emura; Ryuichi Iwakiri; Iwata Ozaki; Takahisa Eguchi; Naofumi Ono; Keizo Anzai; Kazuma Fujimoto; Shunzo Koizumi
Journal:  J Gastroenterol       Date:  2010-11-02       Impact factor: 7.527

Review 3.  Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Authors:  Qing Pang; Jing-Yao Zhang; Si-Dong Song; Kai Qu; Xin-Sen Xu; Su-Shun Liu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

4.  Factors associated with visceral fat accumulation in the general population in Okinawa, Japan.

Authors:  Shingo Arakaki; Tatsuji Maeshiro; Akira Hokama; Kunikazu Hoshino; Shuichi Maruwaka; Miwa Higashiarakawa; Gretchen Parrott; Tetsuo Hirata; Kozen Kinjo; Jiro Fujita
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

5.  Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis).

Authors:  Geoffrey H Tison; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Moyses Szklo; Jingzhong Ding; Matthew J Budoff
Journal:  Am J Cardiol       Date:  2015-05-21       Impact factor: 2.778

6.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.

Authors:  Yuichiro Eguchi; Hideyuki Hyogo; Masafumi Ono; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

7.  Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease.

Authors:  Yoichiro Kitajima; Yuichiro Eguchi; Eriko Ishibashi; Shunya Nakashita; Shigehisa Aoki; Shuji Toda; Toshihiko Mizuta; Iwata Ozaki; Naofumi Ono; Takahisa Eguchi; Kohei Arai; Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-11-03       Impact factor: 7.527

8.  A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff.

Authors:  Noriko Oza; Yuichiro Eguchi; Toshihiko Mizuta; Eriko Ishibashi; Yoichiro Kitajima; Hiroko Horie; Michiko Ushirogawa; Takeko Tsuzura; Shunya Nakashita; Hirokazu Takahashi; Yasunori Kawaguchi; Yasutomo Oda; Ryuichi Iwakiri; Iwata Ozaki; Takahisa Eguchi; Naofumi Ono; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-09-01       Impact factor: 7.527

Review 9.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

10.  Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity.

Authors:  Nihal Hatipoğlu; Serap Doğan; M Mümtaz Mazıcıoğlu; Selim Kurtoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.